DK
Daniel G Kaye
Director

Daniel G Kaye insider trades: Cme Group (CME) stock buys and sales

Director, Cme Group Last trade May 22, 2025 41 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2012
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 22, 2025CME↓ Sell$141K
May 12, 2025EQH↓ Sell$311K
May 12, 2025AB↓ Sell$197K
Dec 20, 2023EQH↓ Sell$164K
Mar 19, 2020EQH↑ Buy$87K
Mar 12, 2020EQH↑ Buy$89K
May 10, 2018EQH↑ Buy$120K
Oct 2, 2015FGP↑ Buy$98K
Jun 24, 2015FGP↑ Buy$231K
Jun 16, 2015FGP↑ Buy$162K
Mar 20, 2015FGP↑ Buy$22K
Oct 9, 2014FGP↑ Buy$26K
Dec 17, 2012FGP↑ Buy$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CME insiders

Open-market trades in the last 12 months

About Daniel G Kaye's insider trades

Daniel G Kaye is a director at Cme Group (CME). Since Dec 17, 2012, Daniel has reported 9 open-market purchases worth $855K and 4 sales worth $813K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (28 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.